Mpamba Recharge & Win

Job Detail


Job Description

KNCV Tuberculosis Foundation is an international non-profit organization dedicated to the fight against tuberculosis (TB), the first deadliest infectious disease in the world. KNCV is an international center of expertise for TB control that promotes effective, efficient, innovative and sustainable tuberculosis control strategies in a national and international context.

We are an organization of passionate TB professionals, including doctors, researchers, training experts, nurses and epidemiologists. We aim to stop the spread of the worldwide epidemic of TB and to prevent the further spread of drug-resistant TB. We operate from a central office in The Hague in the Netherlands, a regional office in Central Asia and country offices worldwide. KNCV raises funds from private, institutional, corporate, and government donors.


Latent tuberculosis (TB) infection (LTBI) is the seed bed for developing TB disease and continued transmission as it’s estimated that close to a quarter of the world’s population has LTBI. The World Health Organization (WHO) policy to give at least six months of isoniazid preventive therapy (IPT) to people living with HIV (PLWHIV) and child contacts has existed since 1993, yet the uptake of IPT in high burden countries remains poor. A short-course regimen of isoniazid and rifapentine weekly for three months (3HP) is now available. 3HP is associated with less toxicity, better adherence and at least similar efficacy to IPT and may be logistically easier for programs to scale up. WHO has included scaling up TB preventive therapy, particularly short-course regimens, in its End TB strategy? implementation of 3HP will meet the same fate as IPT unless existing barriers to its supply, adoption, demand and delivery are removed.

The IMPAACT4TB consortium is led by the Aurum Institute with core partners Clinton Health Access Initiative, Johns Hopkins University (JHU), KNCV Tuberculosis Foundation and the Global Drug Facility. The goal of the IMPAACT4TB project is to reduce TB incidence among PLHIV and child contacts<5 living in low and middle-income countries by contributing to the sustainable scale up of 3HP preventive therapy. The project will utilize the UNITAID grant to start 400,000 people on 3HP and catalyze an increase in supply, demand for and uptake of 3HP in focus countries with the outcome of starting >1 million child contacts and PLWHIV on 3HP. JHU is leading a cluster randomized trial in Malawi called “Choice Architecture Based TB Preventive Therapy Prescribing”. The primary objective of this study is to use a feasible, low-resource strategy to achieve levels of 3HP delivery substantially higher than routine implementation in primary care public clinics. The study protocol received conditional approval from the WHO ERC in January, local IRS approvals are underway. KNCV is leading the implementation process in Ethiopia, Tanzania, Malawi, and Indonesia.

KNCV Tuberculosis Foundation is looking for full time

Research assistants for IMPAACT4TB Project (4 positions)

Duty Station: Mzimba North and Mulanje, Malawi – 2 in each district

Position in the organization

Research Assistants will collect data and lead monitoring and evaluation of Choice architecture based TPT Study activities. He/she will report directly to the Study Coordinator and will maintain close communication and coordination with the IMPAACT4TB Project Manager. The positions are available at the district level with frequent visits to the assigned study sites in the district.

The positions are expected to be filled soon after approval of the protocol by ERB.

Who are we looking for?

  • You have a diploma or degree in any health-related field such as Clinical Medicine, Social Science, public health, statistics or epidemiology.
  • At least 1 year of health information and data management experience;
  • demonstrated experience (at least 1 year) working in communicable disease program/research projects and interventions; proficiency in using data management platforms, such as ODK, REDCap, or Epi-info preferred;
  • conversant with different M & E tools, surveys, evaluations and surveillance systems;
  • experience in qualitative research and conducting in-depth interviews preferred;
  • familiarity with DHIS2 will be an added advantage, experience in working in a non-governmental health project is an added advantage; and
  • In depth knowledge of TB and LTBI from clinical and programmatic perspectives based on local NTP and WHO policies preferred.

What does KNCV Tuberculosis Foundation offer?

A fixed-term contract for a year with a possibility for extension depending on availability of funds;
  • An informal work atmosphere in an international environment where a pro-active mentality is appreciated;
  • A highly-motivated team of experienced, self-driven colleagues;
  • The salary is dependent upon education and relevant working experience;
  • KNCV Tuberculosis Foundation has its own Employment Conditions Scheme;
  • Full-time employment consists of 40 hours per week

How to appy

Application and information You can apply for this position by submitting your CV, including a motivation letter and 3 professional references, before March 8th, 2020 via .

If you have any questions, feel free to contact our team in Malawi via +265 992 891 646; +265 999 585 042 or +265 996 208 768.

Only shortlisted candidates will be contacted for interviews.

Please note that we only consider the applications that are received through the KNCV website. Applications that are sent to recruitment email account are not taken into consideration

Skills Required

Related Jobs

Job Detail

  • Location
  • Company
  • Type
    Full Time
  • Positions
  • Apply Before
    09 Mar, 2020

Google Map